CEN/TC 140
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
61390 | LVS EN ISO 15195:2019 | Laboratory medicine - Requirements for the competence of calibration laboratories using reference measurement procedures (ISO 15195:2018) | Standarts spēkā |
60817 | LVS EN ISO 23640:2015 | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents (ISO 23640:2011) | Standarts spēkā |
70931 | EN ISO 18113-3:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 3: In vitro diagnostic instruments for professional use (ISO 18113-3:2022) | Standarts spēkā |
68066 | LVS EN ISO 23118:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma (ISO 23118:2021) | Standarts spēkā |
67445 | LVS CEN/TS 17688-2:2022 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 2: Isolated proteins | Standarts spēkā |
60818 | EN ISO 15197:2015 | In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013) | Standarts spēkā |
60817 | EN ISO 23640:2015 | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents (ISO 23640:2011) | Standarts spēkā |
67448 | LVS CEN/TS 17688-3:2022 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 3: Isolated genomic DNA | Standarts spēkā |
70930 | EN ISO 18113-2:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO 18113-2:2022) | Standarts spēkā |
75465 | CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
Displaying 211-220 of 272 results.